{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:44:48Z","timestamp":1792107888505,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Delayed gastric conduit emptying (DGCE) is common in patients following esophagectomy, and its treatment remains challenging. This study evaluated efficacy and safety of gastric peroral endoscopic pyloromyotomy (GPOEM) and predictors of treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively included patients with symptoms of DGCE following esophagectomy scheduled for GPOEM in two tertiary referral centers. EndoFLIP measurements were conducted before and 3 months after GPOEM. Gastric emptying scintigraphy (GES) was performed prior to, 3 and 12 months after GPOEM. Efficacy was evaluated by clinical success, defined as a score of 1 or 2 on a six-point Likert scale 3 months after GPOEM. Predictive factors for clinical success, including pyloric distensibility, GES and response to prior pylorus-directed therapy (botulinum injection and pyloric dilatation), were evaluated by exploratory analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The technical success rate of GPOEM was 95% (19\/20; 95% CI 75\u2013100). At 3-, and 12-months post-procedure, the clinical success rates were 68% (13\/19; 95% CI 37\u201384) and 44% (8\/18; 95% CI 22\u201367). Distensibility prior to GPOEM did not differ significantly between patients with and without clinical success (3.7 vs. 4.0 mm\n                      <jats:sup>2<\/jats:sup>\n                      \/mmHg, p\u00a0=\u00a00.70). Pre-GPOEM 4-h gastric retention was greater in patients with clinical success than those without, but this was not significant (33 vs 16%, p\u00a0=\u00a00.12). Although there was no significant association between prior response to pylorus-directed therapy and GPOEM success (p\u00a0=\u00a00.10), the positive and negative predictive value were 100% (9\/9; 95% CI 66\u2013100) and 40% (2\/5; 95% CI 5\u201385).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GPOEM is feasible and safe in patients with DGCE following esophagectomy, demonstrating initial efficacy in two-thirds of patients, although this declined to less than half at 1-year follow-up. In exploratory analyses, no predictors of treatment response were identified. Larger studies are needed to investigate if response to pylorus-directed therapy may predict an increased likelihood of treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-13500-2","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:52:55Z","timestamp":1792104775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastric peroral endoscopic pyloromyotomy for delayed gastric conduit emptying: outcomes and predictors of treatment response"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0213-2140","authenticated-orcid":false,"given":"L. S.","family":"Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. C.","family":"\u2018t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. N.","family":"Beaufort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A. J.","family":"Bastiaansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fockens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Noteboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M. G.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Gisbertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. L. A. M.","family":"Weusten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"5","key":"13500_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/lap.2013.0416","volume":"24","author":"B Li","year":"2014","unstructured":"Li B, Zhang JH, Wang C, Song TN, Wang ZQ, Gou YJ et al (2014) Delayed gastric emptying after esophagectomy for malignancy. J Laparoendosc Adv Surg Tech A 24(5):306\u2013311. https:\/\/doi.org\/10.1089\/lap.2013.0416","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"13500_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2017.02.012","volume":"213","author":"L Zhang","year":"2017","unstructured":"Zhang L, Hou SC, Miao JB, Lee H (2017) Risk factors for delayed gastric emptying in patients undergoing esophagectomy without pyloric drainage. J Surg Res 213:46\u201350. https:\/\/doi.org\/10.1016\/j.jss.2017.02.012","journal-title":"J Surg Res"},{"issue":"3","key":"13500_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00423-017-1576-7","volume":"402","author":"F Benedix","year":"2017","unstructured":"Benedix F, Willems T, Kropf S, Schubert D, Stubs P, Wolff S (2017) Risk factors for delayed gastric emptying after esophagectomy. Langenbecks Arch Surg 402(3):547\u2013554. https:\/\/doi.org\/10.1007\/s00423-017-1576-7","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"13500_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.athoracsur.2010.12.055","volume":"91","author":"M Lanuti","year":"2011","unstructured":"Lanuti M, DeDelva P, Morse CR, Wright CD, Wain JC, Gaissert HA et al (2011) Management of delayed gastric emptying after esophagectomy with endoscopic balloon dilatation of the pylorus. Ann Thorac Surg 91(4):1019\u20131024. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.12.055","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"13500_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-018-0347-x","volume":"18","author":"S Fritz","year":"2018","unstructured":"Fritz S, Feilhauer K, Schaudt A, Killguss H, Esianu E, Hennig R et al (2018) Pylorus drainage procedures in thoracoabdominal esophagectomy - a single-center experience and review of the literature. BMC Surg 18(1):13. https:\/\/doi.org\/10.1186\/s12893-018-0347-x","journal-title":"BMC Surg"},{"issue":"1","key":"13500_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MCG.0000000000000728","volume":"52","author":"BE Lacy","year":"2018","unstructured":"Lacy BE, Crowell MD, Mathis C, Bauer D, Heinberg LJ (2018) Gastroparesis: quality of life and health care utilization. J Clin Gastroenterol 52(1):20\u201324. https:\/\/doi.org\/10.1097\/MCG.0000000000000728","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"13500_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14087","volume":"33","author":"HP Parkman","year":"2021","unstructured":"Parkman HP, Wilson LA, Yates KP, Koch KL, Abell TL, McCallum RW et al (2021) Factors that contribute to the impairment of quality of life in gastroparesis. Neurogastroenterol Motil 33(8):e14087. https:\/\/doi.org\/10.1111\/nmo.14087","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"13500_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cgh.2023.10.014","volume":"22","author":"WL Hasler","year":"2024","unstructured":"Hasler WL, Lee AA, Moshiree B, Surjanhata BC, Rao S, Parkman HP et al (2024) Benefits of prokinetics, gastroparesis diet, or neuromodulators alone or in combination for symptoms of gastroparesis. Clin Gastroenterol Hepatol 22(4):867-877 e812. https:\/\/doi.org\/10.1016\/j.cgh.2023.10.014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"13500_CR9","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/j.cgh.2021.05.063","volume":"20","author":"I Sarosiek","year":"2022","unstructured":"Sarosiek I, Van Natta M, Parkman HP, Abell T, Koch KL, Kuo B et al (2022) Effect of domperidone therapy on gastroparesis symptoms: results of a dynamic cohort study by NIDDK Gastroparesis Consortium. Clin Gastroenterol Hepatol 20(3):e452\u2013e464. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.063","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"13500_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1365-2036.2007.03467.x","volume":"26","author":"J Arts","year":"2007","unstructured":"Arts J, Holvoet L, Caenepeel P, Bisschops R, Sifrim D, Verbeke K et al (2007) Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 26(9):1251\u20131258. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03467.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"13500_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1572-0241.2007.01676.x","volume":"103","author":"FK Friedenberg","year":"2008","unstructured":"Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB (2008) Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 103(2):416\u2013423. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01676.x","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"13500_CR12","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1007\/s00464-022-09230-w","volume":"36","author":"H Soliman","year":"2022","unstructured":"Soliman H, Oiknine E, Cohen-Sors B, Moszkowicz D, Gorbatchef C, Dior M et al (2022) Efficacy and safety of endoscopic pyloric balloon dilation in patients with refractory gastroparesis. Surg Endosc 36(11):8012\u20138020. https:\/\/doi.org\/10.1007\/s00464-022-09230-w","journal-title":"Surg Endosc"},{"issue":"2","key":"13500_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejcts.2006.11.010","volume":"31","author":"M Lanuti","year":"2007","unstructured":"Lanuti M, de Delva PE, Wright CD, Gaissert HA, Wain JC, Donahue DM et al (2007) Post-esophagectomy gastric outlet obstruction: role of pyloromyotomy and management with endoscopic pyloric dilatation. Eur J Cardiothorac Surg 31(2):149\u2013153. https:\/\/doi.org\/10.1016\/j.ejcts.2006.11.010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"13500_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/gutjnl-2020-322756","volume":"71","author":"K Vosoughi","year":"2022","unstructured":"Vosoughi K, Ichkhanian Y, Benias P, Miller L, Aadam AA, Triggs JR et al (2022) Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 71(1):25\u201333. https:\/\/doi.org\/10.1136\/gutjnl-2020-322756","journal-title":"Gut"},{"issue":"4","key":"13500_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cgh.2020.05.039","volume":"19","author":"MM Abdelfatah","year":"2021","unstructured":"Abdelfatah MM, Noll A, Kapil N, Shah R, Li L, Nustas R et al (2021) Long-term outcome of gastric per-oral endoscopic pyloromyotomy in treatment of gastroparesis. Clin Gastroenterol Hepatol 19(4):816\u2013824. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.039","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"13500_CR16","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1136\/gutjnl-2022-326904","volume":"71","author":"J Martinek","year":"2022","unstructured":"Martinek J, Hustak R, Mares J, Vackova Z, Spicak J, Kieslichova E et al (2022) Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial. Gut 71(11):2170\u20132178. https:\/\/doi.org\/10.1136\/gutjnl-2022-326904","journal-title":"Gut"},{"key":"13500_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znaf183","author":"D Eckhardt","year":"2025","unstructured":"Eckhardt D, Elshafei M, Fechner K, Diener MK, Huttner FJ (2025) Endoscopic and surgical treatment options for gastroparesis: systematic review and network meta-analysis. Br J Surg. https:\/\/doi.org\/10.1093\/bjs\/znaf183","journal-title":"Br J Surg"},{"issue":"4","key":"13500_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.gie.2019.11.039","volume":"91","author":"M Spadaccini","year":"2020","unstructured":"Spadaccini M, Maselli R, Chandrasekar VT, Anderloni A, Carrara S, Galtieri PA et al (2020) Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc 91(4):746-752 e745. https:\/\/doi.org\/10.1016\/j.gie.2019.11.039","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"13500_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/a-2235-3286","volume":"56","author":"JM Gonzalez","year":"2024","unstructured":"Gonzalez JM, Mion F, Pioche M, Garbay V, Baumstarck K, Boucekine M et al (2024) Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study. Endoscopy 56(5):345\u2013352. https:\/\/doi.org\/10.1055\/a-2235-3286","journal-title":"Endoscopy"},{"issue":"1","key":"13500_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gie.2020.12.030","volume":"94","author":"L Gregor","year":"2021","unstructured":"Gregor L, Wo J, DeWitt J, Yim B, Siwiec R, Nowak T et al (2021) Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a prospective single-center experience with mid-term follow-up (with video). Gastrointest Endosc 94(1):35\u201344. https:\/\/doi.org\/10.1016\/j.gie.2020.12.030","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"13500_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.gie.2016.06.048","volume":"85","author":"MA Khashab","year":"2017","unstructured":"Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S et al (2017) Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc 85(1):123\u2013128. https:\/\/doi.org\/10.1016\/j.gie.2016.06.048","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"13500_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"4","key":"13500_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1023\/B:QURE.0000021689.86296.e4","volume":"13","author":"DA Revicki","year":"2004","unstructured":"Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ et al (2004) Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13(4):833\u2013844. https:\/\/doi.org\/10.1023\/B:QURE.0000021689.86296.e4","journal-title":"Qual Life Res"},{"issue":"8","key":"13500_CR24","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s11605-019-04237-6","volume":"23","author":"HM Hedberg","year":"2019","unstructured":"Hedberg HM, Carbray J, Ujiki MB (2019) Initial experience with endoscopic pyloromyotomy, with description and video of technique. J Gastrointest Surg 23(8):1706\u20131710. https:\/\/doi.org\/10.1007\/s11605-019-04237-6","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"13500_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/apt.14132","volume":"46","author":"JM Gonzalez","year":"2017","unstructured":"Gonzalez JM, Benezech A, Vitton V, Barthet M (2017) G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 46(3):364\u2013370. https:\/\/doi.org\/10.1111\/apt.14132","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"13500_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"13500_CR27","unstructured":"Castor (2025) Castor electronic data capture. https:\/\/www.castoredc.com"},{"issue":"3","key":"13500_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.gie.2022.03.025","volume":"96","author":"OV Hernandez Mondragon","year":"2022","unstructured":"Hernandez Mondragon OV, Contreras LFG, Velasco GB, Pineda OMS, Carrillo DMC, Perez EM (2022) Gastric peroral endoscopic myotomy outcomes after 4 years of follow-up in a large cohort of patients with refractory gastroparesis (with video). Gastrointest Endosc 96(3):487\u2013499. https:\/\/doi.org\/10.1016\/j.gie.2022.03.025","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"13500_CR29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/a-1205-5686","volume":"53","author":"O Ragi","year":"2021","unstructured":"Ragi O, Jacques J, Branche J, Leblanc S, Vanbiervliet G, Legros R et al (2021) One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: a French multicenter study. Endoscopy 53(5):480\u2013490. https:\/\/doi.org\/10.1055\/a-1205-5686","journal-title":"Endoscopy"},{"key":"13500_CR30","doi-asserted-by":"publisher","DOI":"10.1055\/a-2718-4945","author":"PJ Silete","year":"2025","unstructured":"Silete PJ, Houzvickova M, Degand T, Hugova K, Godat S, Branche J et al (2025) Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis following esophagectomy: results from a multicenter series. Endoscopy. https:\/\/doi.org\/10.1055\/a-2718-4945","journal-title":"Endoscopy"},{"issue":"6","key":"13500_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.gie.2025.06.028","volume":"102","author":"R Shah","year":"2025","unstructured":"Shah R, Vedantam S, Bhalla S, Ferrante N, Amin S (2025) A comparison of technical and clinical success between lesser and greater curvature approaches in gastric peroral endoscopic myotomy: an updated systematic review and meta-analysis. Gastrointest Endosc 102(6):789-796 e787. https:\/\/doi.org\/10.1016\/j.gie.2025.06.028","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"13500_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/a-0628-6639","volume":"51","author":"J Jacques","year":"2019","unstructured":"Jacques J, Pagnon L, Hure F, Legros R, Crepin S, Fauchais AL et al (2019) Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function. Endoscopy 51(1):40\u201349. https:\/\/doi.org\/10.1055\/a-0628-6639","journal-title":"Endoscopy"},{"issue":"1","key":"13500_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cgh.2018.04.016","volume":"17","author":"P Mekaroonkamol","year":"2019","unstructured":"Mekaroonkamol P, Dacha S, Wang L, Li X, Jiang Y, Li L et al (2019) Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis. Clin Gastroenterol Hepatol 17(1):82\u201389. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"13500_CR34","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1007\/s00464-024-11184-0","volume":"38","author":"J Tan","year":"2024","unstructured":"Tan J, Wu H, Yang X, Yang Y, Zhang L, Wang P et al (2024) A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis. Surg Endosc 38(12):7416\u20137425. https:\/\/doi.org\/10.1007\/s00464-024-11184-0","journal-title":"Surg Endosc"},{"key":"13500_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000002279","author":"S Khan","year":"2025","unstructured":"Khan S, Shafiq M, Khan MA, Ahmad A, Ehsan N, Ahmad N et al (2025) Short-term and long-term efficacy of gastric peroral endoscopic myotomy for refractory gastroparesis: a meta-analysis. J Clin Gastroenterol. https:\/\/doi.org\/10.1097\/MCG.0000000000002279","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"13500_CR36","doi-asserted-by":"publisher","first-page":"e70021","DOI":"10.1002\/deo2.70021","volume":"5","author":"FV Mandarino","year":"2025","unstructured":"Mandarino FV, Barchi A, Salmeri N, Azzolini F, Fasulo E, Dell\u2019Anna G et al (2025) Long-term efficacy (at and beyond 1 year) of gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review and meta-analysis. DEN Open 5(1):e70021. https:\/\/doi.org\/10.1002\/deo2.70021","journal-title":"DEN Open"},{"issue":"9","key":"13500_CR37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/ajg.2013.118","volume":"108","author":"P Janssen","year":"2013","unstructured":"Janssen P, Harris MS, Jones M, Masaoka T, Farre R, Tornblom H et al (2013) The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol 108(9):1382\u20131391. https:\/\/doi.org\/10.1038\/ajg.2013.118","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"13500_CR38","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.14309\/ajg.0000000000003213","volume":"120","author":"C Varghese","year":"2024","unstructured":"Varghese C, Lim A, Daker C, Sebaratnam G, Gharibans AA, Andrews CN et al (2024) Predictors of outcomes after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review. Am J Gastroenterol 120(6):1275\u20131284. https:\/\/doi.org\/10.14309\/ajg.0000000000003213","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"13500_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.70187","volume":"37","author":"A Barchi","year":"2025","unstructured":"Barchi A, Gupta M, Warringa N, Mandarino FV, Vespa E, Passaretti S et al (2025) Endoluminal functional lumen imaging probe in the functional assessment of pyloric sphincter in gastroparesis: a systematic review with meta-analysis of normative values. Neurogastroenterol Motil 37(12):e70187. https:\/\/doi.org\/10.1111\/nmo.70187","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"13500_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2025.102031","volume":"29","author":"AE Williams","year":"2025","unstructured":"Williams AE, Bhanat E, Seerapu VN, Salvemini J, Howell G, Evans MM et al (2025) Gastric peroral pyloromyotomy effectiveness in management of all types of gastroparesis. J Gastrointest Surg 29(6):102031. https:\/\/doi.org\/10.1016\/j.gassur.2025.102031","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"13500_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1055\/a-2619-4638","volume":"57","author":"A Farooq","year":"2025","unstructured":"Farooq A, Bani Fawwaz B, Zhang Y, Hasan MK, Mian A, Khan H et al (2025) Prospective analysis of endoscopic measurement of pyloric impedance planimetry and its association with clinical outcomes of gastric peroral endoscopic myotomy. Endoscopy 57(11):1197\u20131205. https:\/\/doi.org\/10.1055\/a-2619-4638","journal-title":"Endoscopy"},{"issue":"6","key":"13500_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.gie.2020.01.044","volume":"91","author":"K Vosoughi","year":"2020","unstructured":"Vosoughi K, Ichkhanian Y, Jacques J, Aadam AA, Benias PC, Law R et al (2020) Role of endoscopic functional luminal imaging probe in predicting the outcome of gastric peroral endoscopic pyloromyotomy (with video). Gastrointest Endosc 91(6):1289\u20131299. https:\/\/doi.org\/10.1016\/j.gie.2020.01.044","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"13500_CR43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5056\/jnm22053","volume":"29","author":"B Yim","year":"2023","unstructured":"Yim B, Gregor L, Siwiec RM, Al-Haddad M, Nowak TV, Wo JM (2023) Pyloric functional lumen imaging probe measurements are dependent on balloon position. J Neurogastroenterol Motil 29(2):192\u2013199. https:\/\/doi.org\/10.5056\/jnm22053","journal-title":"J Neurogastroenterol Motil"},{"issue":"9","key":"13500_CR44","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s10620-018-4976-9","volume":"63","author":"Z Malik","year":"2018","unstructured":"Malik Z, Kataria R, Modayil R, Ehrlich AC, Schey R, Parkman HP et al (2018) Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience. Dig Dis Sci 63(9):2405\u20132412. https:\/\/doi.org\/10.1007\/s10620-018-4976-9","journal-title":"Dig Dis Sci"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13500-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:52:57Z","timestamp":1792104777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13500-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":44,"alternative-id":["13500"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13500-2","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bas Weusten has received research funding from Pentax Medical, C2 therapeutics and Acqua Medical, payment for educational events from Pentax Medical, C2 therapeutics, and received Study Materials from Medtronic. Laura Boer was consultant for Pentax Medical, C2 Therapeutics. Suzanne Gisbertz is consultant for Medicaroid, J&J and Olympus. Paul Fockens is consultant for Cook Endoscopy and Olympus. Barbara Bastiaansen, Ilse Beaufort, Chantal t\u2019 Hoen, Loes Noteboom and Caroline Saleh have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}]}}